Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cancer|February 1, 1985
Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human seraG F Springer, C R Taylor, D R Howard, et al.Journal of Pediatric Hematology/Oncology|August 13, 1999
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Yanofsky, S Pritchard, et al.Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1981
Nesidioblastosis in adults. A surgical dilemmaJ K Harness, G W Geelhoed, N W Thompson, et al.Clinical Pharmacology and Therapeutics|July 1, 1995
Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamicsN R Cutler, R D Seifert, M M Schleman, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1997
Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomographyG Gründer, F Yokoi, S J Offord, et al.Mutagenesis|November 1, 1990
Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitroL C Backer, J W Allen, K Harrington-Brock, et al.Medical and Pediatric Oncology|July 9, 1999
Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapyM J Coppes, R Lau, L C Ingram, et al.Journal of Clinical Microbiology|April 1, 1996
Detection of Mycobacterium tuberculosis in respiratory specimens by strand displacement amplification of DNAJ A Down, M A O'Connell, M S Dey, et al.Leukemia|February 21, 2017
Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLLT Munir, D R Howard, L McParland, et al.Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.Pageof 6